CGNNT(000881)2024-11-05 11:25Financial Performance - The company reported losses for three consecutive quarters, primarily due to intense market competition leading to a decrease in gross margin in the new materials sector [1] - The company is actively working to improve its operational situation and has implemented measures to enhance efficiency and reduce costs [1] Strategic Initiatives - The company aims to transform its mature business by moving towards high-end and high-value-added products to achieve higher profitability and competitiveness [1] - There is a focus on increasing investment in technology research and development in the new materials field to launch more competitive products [2] Future Growth Areas - New business expansions, particularly in the healthcare sector, are currently in the investment phase, laying the groundwork for future product and capability development [2] - The company has established an incentive system closely linked to performance, ensuring strict adherence to relevant policies [2] Project Updates - The company has a small number of orders for its proton therapy systems, with production facilities expected to be operational in Q1 2025 [2] - The electronic beam wastewater treatment business has generated revenue since its commercial application, while the proton therapy business is projected to generate income in 2025 [3] Market Confidence - As of October 31, 2024, the number of registered shareholders was 38,900 [3] - The company currently has three proton orders and is actively pursuing additional orders [3]